Archive: September 15th, 2022
0
YishengBio received approval from Philippines for phase 2/3 clinical trials of PIKA Recombinant COVID-19 vaccine

YishengBio received approval from Philippines for phase 2/3 clinical trials of PIKA Recombinant COVID-19 vaccine

MANILA, Philippines - YishengBio Co., Ltd., ("YishengBio"), a biopharmaceutical company dedicated to discovery, development, manufacturing and ...

ASTIG PH Team ASTIG PH Team September 15, 2022
READ MORE +
Copyright © 2026 ASTIG Philippines.
All Rights Reserved.
September 2022
M T W T F S S
 1234
567891011
12131415161718
19202122232425
2627282930  
ASTIG: Philippine News & Reviews
Logo